Mohs Surgery: Patient Satisfaction & Quality of Life (QOL)

Sponsor
University of Miami (Other)
Overall Status
Completed
CT.gov ID
NCT04936906
Collaborator
(none)
40
1
2
11.1
3.6

Study Details

Study Description

Brief Summary

The purpose of this study is to examine whether there is significant difference between two groups: extra care (EC) and usual care (UC) in improvement of patients' quality-of-life (QoL) scores between the baseline and 90-day post-surgery in patients undergoing Mohs micrographic surgery (MMS).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Extra Care (EC) Intervention
  • Other: Usual Care (UC)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Patient Satisfaction Improvement and Quality of Life Measurement in Mohs Surgery
Actual Study Start Date :
Jul 2, 2019
Actual Primary Completion Date :
Jun 3, 2020
Actual Study Completion Date :
Jun 3, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Extra Care (EC) Treatment Group

Participants in this group will receive the EC intervention pre and post standard of care (SoC) scheduled Mohs Surgery.

Behavioral: Extra Care (EC) Intervention
The EC intervention includes pre- and post- procedure calls from the surgeon, written educational material, personalized music during the operation, post-procedure skin cancer protection education, and are allowed to bring a guest into the procedure room.

Active Comparator: Usual Care (UC) Group

Participants in this group will receive the usual care provided to patients undergoing standard of care (SoC) scheduled Mohs Surgery.

Other: Usual Care (UC)
Standard of care pre and post surgery management provided to patients undergoing Mohs Surgery.

Outcome Measures

Primary Outcome Measures

  1. Change in PSQ Scores [Baseline, 3 months]

    Patient Satisfaction Questionnaire (PSQ) is a 7 item questionnaire with a total score ranging from 7 to 35 with the higher score indicating greater satisfaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Female and/or male subjects undergoing Mohs micrographic surgery for Basal Cell Carcinoma (BCC) and/or Squamous Cell Carcinoma (SCC).

  2. Subjects must be at least 18 years of age.

Exclusion Criteria:
  1. Subjects who are not able to complete the surveys (pre-surgery, 1 week post-surgery, and 3 months post- surgery)

  2. Subjects under the age 18

  3. Subjects unable to consent

  4. Subjects who are not undergoing Mohs micrographic surgery for Basal Cell Carcinoma (BCC) or Squamous Cell Carcinoma (SCC).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Miami Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami

Investigators

  • Principal Investigator: Keyvan Nouri, MD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Keyvan Nouri, Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT04936906
Other Study ID Numbers:
  • 20180626
First Posted:
Jun 23, 2021
Last Update Posted:
Jun 23, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 23, 2021